Teva Pharms Inc Drug Patent Portfolio

Teva Pharms Inc owns 1 orange book drug protected by 1 US patent Given below is the list of Teva Pharms Inc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11072586 Solid state forms of eltrombopag choline 05 Nov, 2038
Active


Teva Pharms Inc's Family Patents


Family Patents



Teva Pharms Inc Drug List

Given below is the complete list of Teva Pharms Inc's drugs and the patents protecting them.


1. Alvaiz

Alvaiz is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11072586 Solid state forms of eltrombopag choline 05 Nov, 2038
(13 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Alvaiz's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Teva Pharms Inc News

Teva's Loss in the Orange Book Leads to a Reevaluation of Pharmaceutical Patent Strategies

11 Jun, 2025

Three Generic Pharmaceutical Stocks to Monitor in Light of Pricing Challenges and Tariff Risks - TradingView

09 Jun, 2025

What factors are driving a 7.2% CAGR growth in the APAC Generic Drugs Market through 2034?

02 Jun, 2025

Federal Trade Commission Pursues Actions to Remove Patents from Drug Device Administration in ...

27 May, 2025

See More